Detection of glucose intolerance after heart attack

June 20, 2002

A Swedish study in this week's issue of THE LANCET confirms that people admitted to hospital with an acute heart attack are at an increased risk of having undiagnosed diabetes or increased glucose intolerance. Findings of the new study suggest that the fasting glucose of patients or high glucose concentrations immediately after heart attack could be a marker of patients at high risk of subsequent cardiovascular disease.

People with diabetes who have myocardial infarction (heart attack) are more likely to die than those without diabetes. Previous research indicates that people with prediabetic conditions, such as impaired glucose tolerance, have an increased risk of cardiovascular disease, and that a blood glucose concentration below the threshold for diabetes is associated with coronary artery disease. Anna Norhammar from the Karolinska Hospital, Stockholm, Sweden, and colleagues aimed to find out the prevalence of impaired glucose metabolism in patients with myocardial infarction but in whom diabetes had not been diagnosed.

181 patients admitted to two Swedish coronary care units with acute myocardial infarction and no diagnosis of diabetes were studied. The investigators recorded glucose concentrations during the hospital stay, and did standardised oral glucose tolerance tests with 75 g of glucose at discharge (four to five days after admission) and again 3 months later.

35% and 40% of patients had impaired glucose tolerance at hospital discharge and after three months, respectively. 31% and 25%, respectively, had previously undiagnosed diabetes. Concentrations of glucose in red blood cells at hospital admission and fasting blood glucose concentrations at discharge were independent predictors of abnormal glucose tolerance.

In an accompanying Commentary, Stephen Haffner from the University of Texas, USA, states: "...in view of the high risk of future coronary heart disease in patients with diabetes, it is reasonable to suggest an oral glucose-tolerance test at discharge after a myocardial infarction. Although the glucose-tolerance test is burdensome for screening in the general population, it is less so in hospitalised patients. The high frequency of newly discovered diabetes is also important because intensive glycaemic control with insulin during the peri-infarction period followed by improved glycaemic control as outpatients lowers the mortality from acute myocardial infarction."
-end-
Contact: Professor Lars Rydén, Department of Cardiology, Karolinska Hospital, 171 76 Stockholm, Sweden; T) +46 8 5177 2171; F) +46 8 311044; E) lars.ryden@ks.se

Professor Stephen M Haffner, University of Texas Health Science Center at San Antonio, Department of Medicine, San Antonio, TX 78229-3900, USA; E) haffner@uthscsa.edu

Lancet

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.